$1.49
Today
as of Sep 4, 16:55 ET
Last 30 days
Recent Press Releases & News
Vivani Medical Announces Participation in Upcoming Investor Conferences
Vivani Medical: Q2 Earnings Snapshot
Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update
Overview
52-week range
$0.92
$1.92
57% of range
Avg surprise (last 3)
-10.0%
Avg reaction (last 2)
+1.8%
100% positive
Latest IV / EM
1189%
EM ±49.6% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.07 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.08 | $-0.08 | 0.0% | +27.3% | +1.8% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.11 | — | — | — | — | financials |
| Wed Aug 13, 2025 | Jun/2025 | $-0.12 | $-0.10 | -20.0% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.11 | $-0.10 | -10.0% | — | +1.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.11 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.10 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.12 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.13 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.13 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $0 | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-7M | $-7M | — | $-7M | $-7M | $-7M | — | $-6M |
| Net income | $-6M | $-7M | — | $-7M | $-7M | $-6M | — | $-6M |
| EPS (diluted) | $-0.07 | $-0.08 | — | $-0.11 | $-0.12 | $-0.11 | — | $-0.11 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $20M | $20M | $16M | $3M | $7M | $13M | $18M | $20M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $22M | $22M | $18M | $4M | $9M | $15M | $20M | $21M |
| Total assets | $42M | $42M | $39M | $25M | $29M | $35M | $42M | $43M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $23M | $23M | $24M | $24M | $24M | $24M | $24M | $25M |
| Total equity | $19M | $19M | $16M | $1M | $5M | $12M | $18M | $18M |